Your browser doesn't support javascript.
loading
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Pinto, Navin; DuBois, Steven G; Marachelian, Araz; Diede, Scott J; Taraseviciute, Agne; Glade Bender, Julia L; Tsao-Wei, Denice; Groshen, Susan G; Reid, Joel M; Haas-Kogan, Daphne A; Reynolds, C Patrick; Kang, Min H; Irwin, Meredith S; Macy, Margaret E; Villablanca, Judith G; Matthay, Katherine K; Park, Julie R.
Afiliação
  • Pinto N; Seattle Children's Hospital, University of Washington, Seattle, Washington.
  • DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.
  • Marachelian A; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Diede SJ; Global Clinical Development-Oncology, Merck Research Laboratories, North Wales, Pennsylvania.
  • Taraseviciute A; Seattle Children's Hospital, University of Washington, Seattle, Washington.
  • Glade Bender JL; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York City, New York.
  • Tsao-Wei D; Department of Preventative Medicine, University of Southern California, Los Angeles, California.
  • Groshen SG; Department of Preventative Medicine, University of Southern California, Los Angeles, California.
  • Reid JM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
  • Haas-Kogan DA; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Reynolds CP; Cancer Center and Cell Biology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas.
  • Kang MH; Cancer Center and Cell Biology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas.
  • Irwin MS; Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
  • Macy ME; Pediatric Hematology/Oncology/Bone Marrow Transplant, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Villablanca JG; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Matthay KK; UCSF Benioff Children's Hospital, University of California, San Francisco, California.
  • Park JR; UCSF School of Medicine, University of California, San Francisco, California.
Pediatr Blood Cancer ; 65(7): e27023, 2018 07.
Article em En | MEDLINE | ID: mdl-29603591
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia / Neuroblastoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia / Neuroblastoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2018 Tipo de documento: Article